News

BioMAP offers insight into human pharmacological and toxicological properties of compounds, including on- and off-target effects, dose responses, and the discrimination of closely related compounds. The Patent no.

The study, a 48-week, global, double-blind, randomized, placebo-controlled trial, involved nearly 300 previously untreated patients infected with the most common form of hepatitis C virus (HCV), the genotype

REALIZE is the final of three clinical trials conducted as part of a global Phase 3 registration program for telaprevir in treatment-naïve and treatment-failure patients with chronic HCV

OMS103HP did not meet the pre-specified endpoints of these studies. No conclusions were made regarding the drug-effect due to confounding factors in the studies. Omeros chairman and chief

The randomised, double-blind, placebo-controlled, parallel-group, multi-centre Phase III study will evaluate the safety and efficacy dexpramipexole in people with familial or sporadic ALS. The study will enroll approximately

The drug has been approved as a treatment for anemia in adults and children six years of age or older, undergoing chronic hemodialysis who are receiving supplemental epoetin

The designer is expected to help GSK to design its studies that meet key objectives and collect necessary data in a streamlined and efficient manner. Medidata claims that

Laninamivir is an influenza antiviral, known as a neuraminidase inhibitor (LANI) and a treatment for influenza. The contract is designed to provide US based manufacturing and clinical data

Originally, the FDA has requested a permanent injunction against Deltex and its president Kabir Ahmed and vice president Mohidur Khan, as the company allegedly failed to obtain approval